Abivax SA (ABVX)

NASDAQ: ABVX · IEX Real-Time Price · USD

10.70

-0.10 (-0.93%)

Dec 29, 2023, 4:30 PM EST - Market closed

Income Statement (Annual)

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year	2022	2021
Selling, General & Admin	7.49	5.58
Research & Development	48.3	47.78
Other Operating Expenses	9.05	-11.96
Operating Expenses	64.84	41.4
Operating Income	-64.84	-41.4
Interest Expense / Income	7.02	3.56
Other Expense / Income	-11.12	-2.51
Pretax Income	-60.74	-42.45
Net Income	-60.74	-42.45
Shares Outstanding (Basic)	19	15
Shares Outstanding (Diluted)	19	15
Shares Change	23.53%	-
EPS (Basic)	-3.18	-2.75
EPS (Diluted)	-3.18	-2.75
Free Cash Flow	-54.26	-45.1
Free Cash Flow Per Share	-2.84	-2.92
EBITDA	-53.23	-38.59
Depreciation & Amortization	0.49	0.3
EBIT	-53.72	-38.89

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).